GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier

GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimer’s disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier…

Read More

Firings at Federal Health Agencies Decimate Offices That Release Public Records

Public access to government records that document the handling of illnesses, faulty products, and safety lapses at health facilities will slow after mass firings at the federal Department of Health and Human Services swept out staff members responsible for releasing records, according to transparency advocates and health experts. HHS Secretary Robert F. Kennedy Jr.’s layoffs…

Read More